The clinical research of enhanced recovery after laparotomy use different doses of dexmedetomidine with patient-controlled intravenous

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17010657

Enrollment

Unknown

Registered

2017-02-17

Start date

2017-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparotomy

Interventions

Group A: laparotomy 0.08ug/kg.h+Sufentanil 0.045ug·kg·h+Flurbiprofen 100mg

Group A:laparotomy 0.08ug/kg.h+Sufentanil 0.045ug·kg·h+Flurbiprofen 100mg

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. laparotom; 2. ASA grade I-II; 3. Aged 20-80 years old.

Exclusion criteria

Exclusion criteria: 1. refuse this study; 2. severe heart, lung, liver and kidey dysfunction; 3. II-III degree atrioventricular block, preoperative SBP<90mmHg, HR<50/min.; 4. preoperative combined with chronic pain and long term use of analgesic drugs, drug abuse, excessive drinking, mental disorder.

Design outcomes

Primary

Measure	Time frame
Ramsay Sedation score;Visual Analogue Scale Score;C-reactionprotein;hypersensitive C-reactive protein;Complement C3;Complement C4;arterial blood gas analysis;number of PCA pump presses;Anal exhaust time;Vital signs change;leucocyte count;	—

Countries

China

Contacts

Public ContactYang Li

The Affiliated Tumor Hospital of Guangxi Medical University

85714727@qq.com+86 18776889066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026